Chronic obstructive pulmonary disease in sub-Saharan Africa: A systematic review

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 5, 2013, Pages 583-589

  Finney, L J ^a   Feary, J R ^b   Leonardi Bee, J ^c   Gordon, S B ^d   Mortimer, Kevin ^d  

^a UNIVERSITY OF MALAWI   (Malawi)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa; Africa South of the Sahara; Chronic obstructive pulmonary disease; Epidemiology

Indexed keywords

AFRICA; ASTHMA; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DUST; EDUCATIONAL STATUS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GAS; HUMAN; INDOOR AIR POLLUTION; PASSIVE SMOKING; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; TUBERCULOSIS;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGED; AGED, 80 AND OVER; CHILD; DEVELOPING COUNTRIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INCOME; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; VITAL CAPACITY; YOUNG ADULT;

EID: 84876878534     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0619     Document Type: Review

References (47)

1. World Health Organization. World Health Statistics 2008. Geneva, Switzerland: WHO, 2008. http://www.who.int/whosis/whostat/EN-WHS08-Full.pdf Accessed October 2012.
2. Abegunde D O, Mathers C D, Adam T, Ortegon M, Strong K. The burden and cost of chronic diseases in low-income and middle-income countries. Lancet 2007; 370: 1928-1938.
3. Lopez A D, Mathers C D, Ezzati M, Jamison D T J, Murray C J L. Global and regional burden of disease and risk factors 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757. (Pubitemid 43767064)
4. Mathers C D, Salomon J A, Ezzati M, Begg S, Lopez A D. Sensitivity and uncertainty analyses for burden of disease and risk factor estimates. In: Lopez A D, Mathers C D, Ezzati M, Murray C J L, Jamison D T, eds. Global burden of disease and risk factors. New York, NY, USA: Oxford University Press, 2006: pp 399-426.
5. United Nations General Assembly. Prevention and control of non-communicable diseases. Report of the Secretary General. New York, NY, USA: UN, 2011.
6. World Health Organization. Prevention and control of chronic respiratory diseases in low and middle income African countries; a preliminary report. 2003. WHO/NMH/CRA/04.1. Geneva, Switzerland: WHO, 2003.
7. United Nations General Assembly, Sixty-fifth session. Note by the Secretary-General transmitting the report by the Director-General of the World Health Organization on the global status of NCDs, with a particular focus on the development challenges faced by developing countries. A/65/362. New York, NY, USA: UN, 2010.
8. Aït-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ 2001; 79: 971-979. (Pubitemid 33027177)
9. Wells G A, Shea B, O'Connell D, et al. The Newcastle-Ottowa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [online publication]. Ottawa, ON, Canada: University of Ottawa, http://www.medicine. mcgill.ca/rtamblyn/Readings%5CThe%20Newcastle%20- %20Scale%20for% 20assessing%20the%20quality%20of%20nonrandomised%20studies% 20in%20meta-analyses.pdf Accessed October 2012.
10. Buist A S, McBurnie M A, Vollmer W M, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750. (Pubitemid 47321907)
11. Lamprecht B, McBurnie M A, Vollmer W M, et al. COPD in never smokers: results from the population-based Burden of Obstructive Lung Disease Study. Chest 2011; 139: 752-763.
12. Wicht C L, de Kock M A, van Wyk Kotze T J. An epidemiological study of the diffuse obstructive pulmonary syndrome. S Afr Med J 1977; 52 (Suppl): 1-15.
13. Girdler-Brown B V, White N W, Ehrlich R I, Churchyard G J. The burden of silicosis, pulmonary tuberculosis and COPD among former Basotho gold-miners. Am J Ind Med 2008; 51: 640-647.
14. Myers J E, Cornell J E. Respiratory health of brickworkers in Cape Town, South Africa. Symptoms, signs and pulmonary function abnormalities. Scand J Work Environ Health 1989; 15: 188-194. (Pubitemid 19166814)
15. Gathuru I M, Bunker C H, Ukoli F A, Egbagbe E E. Differences in rates of obstructive lung disease between Africans and African Americans. Ethn Dis 2002; 12 (Suppl): S3: 107-113.
16. Oleru U G, Onyekwere C. Exposures to polyvinyl chloride, methyl ketone and other chemicals The pulmonary and nonpulmonary effect. Int Arch Occup Environ Health 1992; 63: 503-507.
17. Fullerton D G, Suseno A, Semple S, et al. Wood smoke exposure, poverty and impaired lung function in Malawian adults. Int J Tuberc Lung Dis 2011; 15: 391-398.
18. Martins P, Rosado-Pinto J, Do Ceu Teixeira M, et al. Underreport and underdiagnosis of chronic respiratory diseases in an African country. Eur J Allergy Clin Immunol 2009; 64: 1061-1067.
19. Cookson J B, Mataka G. Prevalence of chronic bronchitis in Rhodesian Africans. Thorax 1978; 33: 328-334. (Pubitemid 8376906)
20. Desalu O O, Adekoya A O, Ampitan B A. Increased risk of respiratory symptoms and chronic bronchitis in women using biomass fuels in Nigeria. J Bras Pneumol 2010; 36: 441-446.
21. Nash E S. Chronic bronchitis - a pilot survey. S Afr Med J 1968; 42: 29-34.
22. Ballal S G. Respiratory symptoms and occupational bronchitis in chromite ore miners, Sudan. J Trop Med Hyg 1986; 89: 223-228. (Pubitemid 17212377)
23. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000; 55: 32-38. (Pubitemid 30248776)
24. Mengesha Y A, Bekele A. Relative chronic effects of different occupational dusts on respiratory indices and health of workers in three Ethiopian factories. Am J Indus Med 1998; 34: 373-380. (Pubitemid 28420637)
25. Peters E J, Esin R A, Immananagha K K, Siziya S, Osim E E. Lung function status of some Nigerian men and women chronically exposed to fish drying using burning firewood. Centr Afr J Med 1999; 45: 119-124.
26. Wiles F J, Faure M H. Chronic obstructive lung disease in gold miners. Inhaled particles 1975; 4: 727-735.
27. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Bethesda, MD, USA: GOLD, 2011. http://www.goldcopd.org/ Accessed October 2012.
28. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986; 133: 1205-1209.
29. Stroup D F, Berlin J A, Morton S C, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012. (Pubitemid 30214957)
30. Halbert R J, Natoll J L, Gano A, Badamgarav E, Buist A S, Mannino D M. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532. (Pubitemid 44794666)
31. Halbert R J, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003; 123: 1684-1692. (Pubitemid 36549792)
32. Chan-Yeung M, Aït-Khaled N, White N, Ip M S, Tan W C. The burden and impact of COPD in Asia and Africa. Int J Tuberc Lung Dis 2004; 8: 2-14. (Pubitemid 38120700)
33. Murray C J L, Lopez A D. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science 1996; 274: 740-743. (Pubitemid 26398244)
34. Chapman K R, Mannino D M, Soriano J B, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2008; 27: 188-207.
35. Stang P, Lydick E, Silberman C, Kempel A, Keating E T. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000; 117 (Suppl 2): 354S-359S. (Pubitemid 30314466)
36. World Bank. World Bank Development Indicators. Washington DC, USA: World Bank, 2005. http://www.dfid.gov.uk/stories/features/2010/world-statistics-day- 2010/ Accessed October 2012.
37. Salvi S S, Barnes P. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374: 733-743.
38. Mannino D M, Buist S B. Global burden of COPD: risk factors, prevalence and future trends. Lancet 2007; 370: 765-773. (Pubitemid 47321908)
39. World Health Organization. Global health risks. Mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: WHO, 2009. http://www.who.int/healthinfo/global-burden-disease/global-health-risks/en/ index.html Accessed October 2012.
40. Jaakkola M S, Jaakkola J J K. Biomass fuels and health. The gap between global prevalence and research activity. Am J Respir Crit Care Med 2006; 174: 851-852. (Pubitemid 44564783)
41. Pauwels R A, Rabe K F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620. (Pubitemid 39094180)
42. The World Bank, Commission of Growth and Development. Urbanisation and growth. Washington DC, USA: World Bank, 2009. http://www.growthcommission.org/ storage/cgdev/documents/ebookurbanization.pdf Accessed October 2012.
43. Menesez A M B, Hallal P C, Perez-Padilla R, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J 2007; 30: 1180-1185. (Pubitemid 351194767)
44. World Health Organization. WHO report on the global tobacco epidemic 2011: warning about the dangers of tobacco. Geneva, Switzerland: WHO, 2011. http://whqlibdoc.who.int/publications/2011/9789240687813-eng.pdf Accessed January 2013.
45. Mehrotra A, Oluwole A M, Gordon S B. The burden of COPD in Africa: a literature review and prospective survey of the availability of spirometry for COPD diagnosis in Africa. Trop Med Int Health 2009; 14: 840-848.
46. American Thoracic Society. Methods in Epidemiologic, Clinical and Operations Research (MECOR). New York, NY, USA: ATS, 2012. http://www.thoracic. org/global-health/mecorcourses/index.php Accessed October 2012.
47. World Health Organization. Preventing chronic diseases: a vital investment. WHO Global Report. Geneva, Switzerland: WHO, 2005. http://www.who.int/chp/chronic-disease-report/ Accessed October 2012.